Financhill
Back

EPAM Systems Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
23

EPAM
EPAM Systems

Last Price:
$175.82
Seasonality Move:
12.77%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$17.45
Seasonality Move:
5.74%
Sell
23
EPAM Systems (EPAM) is a Sell

Is EPAM Systems a Buy, Sell or Hold?

  • The current EPAM Systems [EPAM] share price is $180.63. The Score for EPAM is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • EPAM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.78. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EPAM Stock Price Chart

What is EPAM Systems's stock price today?

  • The EPAM Systems share price today is $180.63
    The current trend is moderately bullish and EPAM is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

EPAM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 12.1 Buy
Relative Strength Index (14 RSI): 58.84 Buy
Chaikin Money Flow: -717678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (153.56 - 182.24) Buy
Bollinger Bands (100): (161.79 - 239.25) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 44.9 Sell
Chaikin Money Flow: 1310696 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.04 - 19.02) Sell
Bollinger Bands (100): (19.37 - 29.83) Sell

EPAM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 184.18 Sell
20-day SMA: 172.33 Buy
50-day SMA: 166.66 Buy
200-day SMA: 206.63 Sell
8-day EMA: 181.76 Sell
20-day EMA: 172.85 Buy
50-day EMA: 140.62 Buy
200-day EMA: 60.01 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.4 Buy
20-day SMA: 18.11 Sell
50-day SMA: 20.11 Sell
200-day SMA: 28.63 Sell
8-day EMA: 17.67 Buy
20-day EMA: 18.1 Sell
50-day EMA: 20.2 Sell
200-day EMA: 28.78 Sell

EPAM Systems Earnings Growth & EPAM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.65 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.04 per share, and an increase next year of $1.27 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

EPAM Systems Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):